MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Kurashige, Junji ^a   Kamohara, Hidenobu ^a   Watanabe, Masayuki ^a   Hiyoshi, Yukiharu ^a   Iwatsuki, Masaaki ^a   Tanaka, Youhei ^a   Kinoshita, Koichi ^a   Saito, Seiya ^a   Baba, Yoshifumi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 200B; UNCLASSIFIED DRUG; UVOMORULIN; ZINC FINGER E BOX BINDING HOMEOBOX 1 PROTEIN; ZINC FINGER E BOX BINDING HOMEOBOX 2 PROTEIN; ZINC FINGER PROTEIN;

AGED; ARTICLE; CANCER SURGERY; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR VOLUME; UPREGULATION;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR BURDEN; UP-REGULATION;

EID: 84864966395     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2217-6     Document Type: Article

References (39)

1. P Hohenberger S Gretschel 2003 Gastric cancer Lancet. 362 9380 305 315 12892963 10.1016/S0140-6736(03)13975-X
2. Y Yuasa 2003 Control of gut differentiation and intestinal-type gastric carcinogenesis Nat Rev Cancer. 3 592 600 12894247 10.1038/nrc1141 1:CAS:528:DC%2BD3sXlvV2iu74%3D
3. M Jechlinger S Grunert IH Tamir, et al. 2003 Expression profiling of epithelial plasticity in tumor progression Oncogene. 22 7155 7169 14562044 10.1038/sj.onc.1206887 1:CAS:528:DC%2BD3sXotFemsr0%3D
4. JP Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer. 2 442 454 12189386 10.1038/nrc822 1:CAS:528:DC%2BD38Xksl2ltr8%3D
5. JP Thiery 2003 Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol. 15 740 746 14644200 10.1016/j.ceb.2003.10.006 1:CAS:528:DC%2BD3sXptlyks7c%3D
6. E Batlle E Sancho C Franci, et al. 2000 The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat Cell Biol. 2 84 89 10655587 10.1038/35000034 1:CAS:528:DC%2BD3cXhtVyltLo%3D
7. J Yang SA Mani JL Donaher, et al. 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell. 117 927 939 15210113 10.1016/j.cell.2004.06.006 1:CAS:528:DC%2BD2cXlsFWnu7w%3D
8. A Eger K Aigner S Sonderegger, et al. 2005 DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene. 24 2375 2385 15674322 10.1038/sj.onc.1208429 1:CAS:528:DC%2BD2MXislClsLo%3D
9. J Comijn G Berx P Vermassen, et al. 2001 The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion Mol Cell. 7 1267 1278 11430829 10.1016/S1097-2765(01)00260-X 1:CAS:528: DC%2BD3MXkvVaqu7g%3D
10. K Aigner B Dampier L Descovich, et al. 2007 The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity Oncogene. 26 6979 6988 17486063 10.1038/sj.onc.1210508 1:CAS:528:DC%2BD2sXht1Wgt7rP
11. C Vandewalle J Comijn B De Craene, et al. 2005 SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions Nucleic Acids Res. 33 6566 6578 16314317 10.1093/nar/gki965 1:CAS:528:DC%2BD2MXhtlSjurfN
12. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell. 116 281 297 14744438 10.1016/S0092-8674(04)00045-5 1:CAS:528: DC%2BD2cXhtVals7o%3D
13. U Wellner J Schubert UC Burk, et al. 2009 The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol. 11 1487 1495 19935649 10.1038/ncb1998 1:CAS:528:DC%2BD1MXhsV2gsLnM
14. PA Gregory AG Bert EL Paterson, et al. 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol. 10 593 601 18376396 10.1038/ncb1722 1:CAS:528: DC%2BD1cXltl2is7c%3D
15. M Korpal ES Lee G Hu, et al. 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J Biol Chem. 283 14910 14914 18411277 10.1074/jbc.C800074200 1:CAS:528:DC%2BD1cXmtlynsbc%3D
16. SM Park AB Gaur E Lengyel, et al. 2008 The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev. 22 894 907 18381893 10.1101/gad.1640608 1:CAS:528:DC%2BD1cXksVGktL4%3D
17. Y Hiyoshi H Kamohara R Karashima, et al. 2009 MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma Clin Cancer Res. 15 1915 1922 19276261 10.1158/1078-0432.CCR-08-2545 1:CAS:528: DC%2BD1MXjtF2rsL0%3D
18. Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One. 2010;5(10).
19. J Yu K Ohuchida K Mizumoto, et al. 2010 MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation Mol Cancer. 9 169 20579395 10.1186/1476-4598-9-169
20. H Xia SS Ng S Jiang, et al. 2010 miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion Biochem Biophys Res Commun. 391 535 541 19931509 10.1016/j.bbrc.2009.11.093 1:CAS:528:DC%2BC3cXpsVCj
21. DW Mueller M Rehli AK Bosserhoff 2009 miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma J Invest Dermatol. 129 1740 1751 19212343 10.1038/jid.2008.452 1:CAS:528:DC%2BD1MXntFCisrg%3D
22. MV Iorio R Visone G Di Leva, et al. 2007 MicroRNA signatures in human ovarian cancer Cancer Res. 67 8699 8707 17875710 10.1158/0008-5472.CAN-07-1936 1:CAS:528:DC%2BD2sXhtVCit7vN
23. Ru GQ, Wang HJ, Xu WJ, et al. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis. Pathol Oncol Res. 2011;17:341-7.
24. MA Kim HS Lee HE Lee, et al. 2009 Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma Histopathology. 54 442 451 19309396 10.1111/j.1365-2559.2009.03247.x
25. C Castro Alves E Rosivatz C Schott, et al. 2007 Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin J Pathol. 211 507 515 17299729 10.1002/path.2138 1:STN:280:DC%2BD2s7ntVyksw%3D%3D
26. M Iwatsuki K Mimori T Fukagawa, et al. 2010 The clinical significance of vimentin-expressing gastric cancer cells in bone marrow Ann Surg Oncol. 17 2526 2533 20358301 10.1245/s10434-010-1041-0
27. XY Zhong LH Zhang SQ Jia, et al. 2008 Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer Histopathology. 52 560 568 18312357 10.1111/j.1365-2559.2008.02971.x
28. E Rosivatz I Becker K Specht, et al. 2002 Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer Am J Pathol. 161 1881 1891 12414534 10.1016/S0002-9440(10)64464-1 1:CAS:528:DC%2BD38XptV2gtbk%3D
29. HS Lee HK Lee HS Kim, et al. 2003 Tumour suppressor gene expression correlates with gastric cancer prognosis J Pathol. 200 39 46 12692839 10.1002/path.1288 1:CAS:528:DC%2BD3sXkt1aktb0%3D
30. Y Yonemura Y Endou K Kimura, et al. 2000 Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer Clin Cancer Res. 6 4234 4242 11106237 1:CAS:528:DC%2BD3cXovVSgtbg%3D
31. SF Tavazoie C Alarcon T Oskarsson, et al. 2008 Endogenous human microRNAs that suppress breast cancer metastasis Nature. 451 7175 147 152 18185580 10.1038/nature06487 1:CAS:528:DC%2BD1cXksVGhuw%3D%3D
32. KJ Png M Yoshida XH Zhang, et al. 2011 MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer Genes Dev. 25 226 231 21289068 10.1101/gad.1974211 1:CAS:528:DC%2BC3MXisVehsbk%3D
33. L Ma J Young H Prabhala, et al. 2010 miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol. 12 247 256 20173740 1:CAS:528:DC%2BC3cXisFems7g%3D
34. L Ma F Reinhardt E Pan, et al. 2010 Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat Biotechnol. 28 341 347 20351690 10.1038/nbt.1618 1:CAS:528:DC%2BC3cXjvFars74%3D
35. D Iliopoulos M Lindahl-Allen C Polytarchou, et al. 2010 Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells Mol Cell. 39 761 772 20832727 10.1016/j.molcel.2010.08.013 1:CAS:528:DC%2BC3cXhtFGjt7zM
36. Y Shimono M Zabala RW Cho, et al. 2009 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell. 138 592 603 19665978 10.1016/j.cell.2009.07.011 1:CAS:528:DC%2BD1MXhsVChs7bP
37. DR Cochrane NS Spoelstra EN Howe, et al. 2009 MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents Mol Cancer Ther. 8 1055 1066 19435871 10.1158/1535-7163.MCT-08-1046 1:CAS:528:DC%2BD1MXmtlGqsLo%3D
38. DR Cochrane EN Howe NS Spoelstra, et al. 2010 Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers J Oncol. 2010 821717 20049172 10.1155/2010/821717
39. S Leskela LJ Leandro-Garcia M Mendiola, et al. 2011 The miR-200 family controls {beta}-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients Endocr Relat Cancer. 18 85 95 21051560 10.1677/ERC-10-0148 1:CAS:528: DC%2BC3MXjsFWqurg%3D